One of the many advantages of additive manufacturing is its ability to produce a diverse range of components. With this in mind, Pete Basiliere, Research Vice President of Additive Manufacturing at the U.S. research and advisory firm Gartner delved into the potential for a business contingency plan based on 3D printing and its digital capabilities. […]
(ZDNet) — A new survey by Gartner reveals that high startup costs and acquisitions are preventing the enterprise from effectively implementing 3D printing into business strategies. Gartner surveyed 330 individuals employed by organizations with at least 100 employees that are using — or planning to use — 3D printing within his/her businesses. Sixty percent of… View Article
(Gartner) The technology of 3D bioprinting (the medical application of 3D printing to produce living tissue and organs) is advancing so quickly that it will spark a major ethical debate on its use by 2016, according to Gartner Inc. The debate will involve a great many political, moral and financial interests. Pete Basiliere, research director at Gartner, cited a number of questions that will need to be addressed: What happens when complex ‘enhanced’ organs involving nonhuman cells are made? Who will control the ability to produce them? Who will ensure the quality of the resulting organs?
New Career Opportunities Daily: The best jobs in media.